Upper Respiratory Infections Linked to Nonadherence to Scheduled Chemotherapy

Share this content:

the Cancer Therapy Advisor take:

A patient’s adherence to their chemotherapy schedule is an integral aspect to an optimal treatment outcome. A prospective cohort study led by Ahmed Taha, MD, of the Sackler Faculty of Medicine, Tel-Aviv University in Tel-Aviv, Israel, looked into the factors that led to a dose reduction, a delay in chemotherapy, or a cancellation of a patient’s planned chemotherapy.

The focus of the research was mainly delays in chemotherapy because of a mild respiratory infection during the winter. The research included 547 adult patients with solid or hematologic cancer who were undergoing chemotherapy in a cancer center during the winter of 2010 to 2011. The researchers determined that 213 of the patients followed (38.9%) experienced 306 delays in chemotherapy treatment.

The documented reasons for the delays in chemotherapy were neutropenia (84/306, 27.4%), fever or infection (73/306, 23.9%), and thrombocytopenia (26/306, 8.5%). Upper respiratory infections (OR 1.87, 95% CI 1.27–2.76), prior hospitalization, lymphopenia, and peripheral vascular disease were all found to be independent risk factors for delayed chemotherapy treatment.

Researchers conducted an adjusted analysis that analyzed nonadherence to chemotherapy only because of an infection, that analysis determined that age alone and an upper respiratory infection (OR 5.25, 95% I 2.81–9.84) were significant independent risk factors. With this knowledge, the researchers encourage clinicians to assist their patients in preventing upper respiratory infections in order to avoid delays in chemotherapy schedules.

Anticipating Possible Adverse Reactions from Chemotherapy Infusions
Factors examined for dose reduction, delay in chemotherapy, or cancellation of a planned chemotherapy.
The authors examined causes for delay or cancellation of planned chemotherapy, focusing on mild respiratory infections during the winter. Nevertheless, the results should encourage modalities to prevent influenza and other upper respiratory infections among cancer patients.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs